Back to Search Start Over

Factors associated with opioid-tapering success: A mixed methods study.

Authors :
Kuntz, Jennifer L.
Dickerson, John F.
Schneider, Jennifer L.
Firemark, Alison J.
Papajorgji-Taylor, Dea
Slaughter, Matthew
Reese, Katherine R.
Thorsness, Lou Ann
Sullivan, Mark D.
Debar, Lynn L.
Smith, David H.
Source :
Journal of the American Pharmacists Association: JAPhA; May2021, Vol. 61 Issue 3, p248-248, 1p
Publication Year :
2021

Abstract

<bold>Objective: </bold>Opioid tapering is recommended when risks of chronic opioid use outweigh benefits. Little is known about patient characteristics or factors related to tapering success. We sought to identify characteristics that predict a 50% reduction in opioid use and qualitatively characterize factors that impact tapering success.<bold>Methods: </bold>We used multilevel hierarchical modeling to identify predictors of a 50% reduction in opioid use among Kaiser Permanente Northwest patients who underwent pharmacist-led tapering between 2012 and 2017. We conducted qualitative interviews among patients and pharmacists to identify factors influencing tapering success.<bold>Results: </bold>We identified 1384 patients who, on average, were dispensed 207 milligram morphine equivalents per day at baseline. After 12 months, 56% of patients reduced their opioid use by 50%. Increased odds of 50% reduction were associated with younger age 21-49 years (Odds ratio [OR] 1.32, P = 0.004); previous surgery (OR 2.24, P < 0.001); increased number of Addiction Medicine encounters (OR 1.25, P = 0.011); substance use disorder (OR 1.62, P = 0.001); anxiety (OR 1.32, P = 0.003); non-narcotic analgesic (OR 1.22, P = 0.025) or antipsychotic medication use (OR 1.53, P = 0.006); and opioid days supplied in the previous year (OR 1.08, P < 0.001). Patients and pharmacists noted that success was influenced by patients' willingness or resistance to change opioid use, the level of patient engagement achieved through communication with their provider, aspects of the tapering process such as pace, and external factors including health issues or caregiving responsibilities.<bold>Conclusions: </bold>Over one-half of patients who underwent tapering reduced their opioid use by 50%. Patient demographic and clinical characteristics were predictive of tapering success; however, patients and pharmacists noted that patient willingness, motivation, and personal circumstances also influence tapering outcome. Opioid tapering requires an individualized approach. Both clinical factors and personal circumstances should be considered when opioid tapering is being discussed as a possible solution for a patient. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15443191
Volume :
61
Issue :
3
Database :
Supplemental Index
Journal :
Journal of the American Pharmacists Association: JAPhA
Publication Type :
Academic Journal
Accession number :
150082701
Full Text :
https://doi.org/10.1016/j.japh.2020.12.019